Strategic Alliance RDI recently formed a strategic alliance with Central Ohio Primary Care Physicians, signaling an opportunity to leverage a large, physician-owned network for patient recruitment and site utilization across decentralized trial designs.

Decentralized Expertise As pioneers in decentralized clinical trials with on-site, hybrid, or fully remote capabilities, RDI can offer sponsors flexible trial designs and faster startup timelines, appealing to sponsors seeking patient-centric and adaptable study execution.

Strong Recruitment RDI maintains a 19,000+ participant database with a 97% retention rate, presenting a clear value proposition for faster enrollment, higher retention, and improved study timelines for potential sponsors.

Regional Focus Deep ties to the Columbus, Ohio community and a modern 7,500-square-foot facility position RDI as a reliable regional partner for trials targeting Midwestern patient populations and healthcare ecosystems.

Financial Scale With reported revenue in the $10–$25 million range and partnerships with global pharma players, there is an opportunity to pursue mid-to-large phase studies or expanded scope collaborations that align with sponsor demand for experienced smaller sites with capabilities.